Antioxidant vitamins and their use in preventing cardiovascular disease

Molecules

Volumn 15, Issue 11, 2010, Pages 8098-8110

  Farbstein, Dan ^a   Kozak Blickstein, Adena ^a   Levy, Andrew P ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antioxidants; Atherosclerosis; CVD; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; VITAMIN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DRUG EFFECT; HUMAN; OXIDATIVE STRESS; REVIEW;

ANTIOXIDANTS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; OXIDATIVE STRESS; VITAMIN E; VITAMINS;

EID: 78649465557     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15118098     Document Type: Review

References (74)

1. Glass, C.K.; Witztum, J.L. Atherosclerosis: The road ahead. Cell 2001, 104, 503-516.
2. Evans, H.M.; Bishop, K.S. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922, 56, 650-651.
3. Niki, E. Antioxidants in relation to lipid peroxidation. Chem. Phys. Lipids 1987, 44, 227-253.
4. Zhang, Y.; Turunen, M.; Appelkvist, E.L. Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alpha-tocopherol into rat organs and cells. J. Nutr. 1996, 126, 2089-2097.
5. Sokol, R.J.; Heubi, J.E.; Iannaccone, S.; Bove, K.E.; Balistreri, W.F. Mechanism causing vitamin E deficiency during chronic childhood cholestasis. Gastroenterology 1983, 85, 1172-1182.
6. Kostner, G.M.; Oettl, K.; Jauhiainen, M.; Ehnholm, C.; Esterbauer, H.; Dieplinger, H. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem. J. 1995, 305, 659-667.
7. Havel, R. McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis- new perspectives. Am. J. Clin. Nutr. 1994, 59, 795-796.
8. Hosomi, A.; Arita, M.; Sato, Y.; Kiyose, C.; Ueda, T.; Igarashi, O.; Arai, H.; Inoue, K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997, 409, 105-108.
9. Brigelius-Flohe, R.; Traber, M.G. Vitamin E: Function and metabolism. FASEB J. 1999, 13, 1145-1155.
10. Mustacich, D.J.; Bruno, R.S.; Traber, M.G. Vitamin E. Vitam. Horm. 2007, 76, 1-21.
11. Mahoney, C.W.; Azzi, A. Vitamin E inhibits protein kinase C activity. Biochem. Biophys. Res. Comm. 1988, 154, 694-697.
12. Boudreau, R.T.; Garduno, R.; Lin, T.J. Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 2002, 277, 5322-5329.
13. Zingg, J.M. Modulation of signal transduction by vitamin E. Mol. Aspects Med. 2007, 28, 481-506.
14. Boscoboinik, D.; Szewczyk, A.; Hensey, C.; Azzi, A. Inhibition of cell proliferation by alphatocopherol. Role of protein kinase C. J. Biol. Chem. 1991, 266, 6188-6194.
15. Tasinato, A.; Boscoboinik, D.; Bartoli, G.M.; Maroni, P.; Azzi, A. d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Nat. Acad. Sci. USA 1995, 92, 12190-12194.
16. de Nigris, F.; Franconi, F.; Maida, I.; Palumbo, G.; Anania, V.; Napoli, C. Modulation by alphaand gamma-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells. Biochem. Pharmacol. 2000, 59, 1477-1487.
17. Wu, D.; Liu, L.; Meydani, M.; Meydani, S.N. Effect of vitamin E on prostacyclin (PGI2) and prostaglandin (PG) E2 production by human aorta endothelial cells: mechanism of action. Ann. New York Acad. Sci. 2004, 1031, 425-427.
18. Heller, R.; Hecker, M.; Stahmann, N.; Thiele, J.J.; Werner-Felmayer, G.; Werner, E.R. Alphatocopherol amplifies phosphorylation of endothelial nitric oxide synthase at serine 1177 and its short-chain derivative trolox stabilizes tetrahydrobiopterin. Free Radic. Biol. Med. 2004, 37, 620-631.
19. Heller, R.; Werner-Felmayer, G.; Werner, E.R. Alpha-Tocopherol and endothelial nitric oxide synthesis. Ann. New York Acad. Sci. 2004, 1031, 74-85.
20. Desideri, G.; Marinucci, M.C.; Tomassoni, G.; Masci, P.G.; Santucci, A.; Ferri, C. Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J. Clin. Endocrinol. Metabol. 2002, 87, 2940-2945.
21. Green, D.; O'Driscoll, G.; Rankin, J.M.; Maiorana, A.J.; Taylor, R.R. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin. Sci. (Lond) 1998, 95, 361-367.
22. Motoyama, T.; Kawano, H.; Kugiyama, K.; Hirashima, O.; Ohgushi, M.; Tsunoda, R.; Moriyama, Y.; Miyao, Y.; Yoshimura, M.; Ogawa, H.; Yasue, H. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J. Am. Coll. Cardiol. 1998, 32, 1672-1679.
23. Neunteufl, T.; Kostner, K.; Katzenschlager, R.; Zehetgruber, M.; Maurer, G.; Weidinger, F. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J. Am. Coll. Cardiol. 1998, 32, 711-716.
24. Heitzer, T.; Yla Herttuala, S.; Wild, E.; Luoma, J.; Drexler, H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J. Am. Coll. Cardiol. 1999, 33, 499-505.
25. McSorley, P.T.; Bell, P.M.; Young, I.S.; Atkinson, A.B.; Sheridan, B.; Fee, J.P.; McCance, D.R. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet. Med. 2005, 22, 703-710.
26. Simons, L.A.; von Konigsmark, M.; Simons, J.; Stocker, R.; Celermajer, D.S. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 1999, 143, 193-199.
27. Elliott, T.G.; Barth, J.D.; Mancini, G.B. Effects of vitamin E on endothelial function in men after myocardial infarction. Am. J. Cardiol. 1995, 76, 1188-1190.
28. McDowell, I.F.; Brennan, G.M.; McEneny, J.; Young, I.S.; Nicholls, D.P.; McVeigh, G.E.; Bruce, I.; Trimble, E.R.; Johnston, G.D. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur. J. Clin. Investig. 1994, 24, 759-765.
29. Yoshikawa, T.; Yoshida, N.; Manabe, H.; Terasawa, Y.; Takemura, T.; Kondo, M. Alpha tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. BioFactors 1998, 7, 15-19.
30. Faruqi, R.; de la Motte, C.; DiCorleto, P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 1994, 94, 592-600.
31. Yoshida, N.; Yoshikawa, T.; Manabe, H.; Terasawa, Y.; Kondo, M.; Noguchi, N.; Niki, E. Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells. J. Leukocyte Bio. 1999, 65, 757-763.
32. Noguchi, N.; Hanyu, R.; Nonaka, A.; Okimoto, Y.; Kodama, T. Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic. Biol. Med. 2003, 34, 1614-1620.
33. Wu, D.; Koga, T.; Martin, K.R.; Meydani, M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999, 147, 297-307.
34. Koga, T.; Kwan, P.; Zubik, L.; Ameho, C.; Smith, D.; Meydani, M. Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis 2004, 176, 265-272.
35. Desideri, G.; Croce, G.; Marinucci, M.C.; Masci, P.G.; Stati, M.; Valeri, L.; Santucci, A.; Ferri, C. Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule- 1 activation. Clin. Chim. Acta 2002, 320, 5-9.
36. van Dam, B.; van Hinsbergh, V.W.; Stehouwer, C.D.; Versteilen, A.; Dekker, H.; Buytenhek, R.; Princen, H.M.; Schalkwijk, C.G. Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects. Cardiovasc. Res. 2003, 57, 563-571.
37. Devaraj, S.; Jialal, I. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic. Biol. Med. 2005, 38, 1212-1220.
38. Devaraj, S.; Jialal, I. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1125-1133.
39. Devaraj, S.; Li, D.; Jialal, I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Investig. 1996, 98, 756-763.
40. Munteanu, A.; Zingg, J.M.; Azzi, A. Anti-atherosclerotic effects of vitamin E-myth or reality? J. Cell. Mol. Med. 2004, 8, 59-76.
41. Munteanu, A.; Taddei, M.; Tamburini, I.; Bergamini, E.; Azzi, A.; Zingg, J.M. Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 2006, 281, 6489-6497.
42. Khanduja, K.L.; Avti, P.K.; Kumar, S.; Pathania, V.; Pathak, C.M. Inhibitory effect of vitamin E on proinflammatory cytokines-and endotoxin-induced nitric oxide release in alveolar macrophages. Life Sci. 2005, 76, 2669-2680.
43. Cachia, O.; Benna, J.E.; Pedruzzi, E.; Descomps, B.; Gougerot-Pocidalo, M.A.; Leger, C.L. alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 1998, 273, 32801-32805.
44. Brigelius-Flohe, R. Vitamin E: the shrew waiting to be tamed. Free Radic. Biol. Med. 2009, 46, 543-554.
45. Carr, A.C.; Zhu, B.Z.; Frei, B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 2000, 87, 349-354.
46. Traber, M.G.; Atkinson, J. Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 4-15.
47. Lonn, E.; Bosch, J.; Yusuf, S.; Sheridan, P.; Pogue, J.; Arnold, J.M.; Ross, C.; Arnold, A.; Sleight, P.; Probstfield, J.; Dagenais, G.R. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293, 1338-1347.
48. Lee, I.M.; Cook, N.R.; Gaziano, J.M.; Gordon, D.; Ridker, P.M.; Manson, J.E.; Hennekens, C.H.; Buring, J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294, 56-65. (Pubitemid 41002839)
49. Kataja-Tuomola, M.K.; Kontto, J.P.; Mannisto, S.; Albanes, D.; Virtamo, J.R. Effect of alphatocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study. Ann. Med. 2010, 42, 178-186.
50. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297, 842-857.
51. Milman, U.; Blum, S.; Shapira, C.; Aronson, D.; Miller-Lotan, R.; Anbinder, Y.; Alshiek, J.; Bennett, L.; Kostenko, M.; Landau, M.; Keidar, S.; Levy, Y.; Khemlin, A.; Radan, A.; Levy, A.P. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 341-347.
52. Levy, A.P.; Gerstein, H.C.; Miller-Lotan, R.; Ratner, R.; McQueen, M.; Lonn, E.; Pogue, J. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diabetes Care 2004, 27, 2767.
53. Blum, S.; Vardi, M.; Levy, N.S.; Miller-Lotan, R.; Levy, A.P. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Atherosclerosis 2010, 211, 25-27.
54. Levy, A.P.; Asleh, R.; Blum, S.; Levy, N.S.; Miller-Lotan, R.; Kalet-Litman, S.; Anbinder, Y.; Lache, O.; Nakhoul, F.M.; Asaf, R.; Farbstein, D.; Pollak, M.; Soloveichik, Y.Z.; Strauss, M.; Alshiek, J.; Livshits, A.; Schwartz, A.; Awad, H.; Jad, K.; Goldenstein, H. Haptoglobin: basic and clinical aspects. Antioxid. Redox Signal. 2010, 12, 293-304.
55. Deruelle, F.; Baron, B. Vitamin C: is supplementation necessary for optimal health? J. Alternative Compl. Med. 2008, 14, 1291-1298.
56. Baron, J.H. Sailors' scurvy before and after James Lind-a reassessment. Nutr. Rev. 2009, 67, 315-332.
57. Aguirre, R.; May, J.M. Inflammation in the vascular bed: importance of vitamin C. Pharmacol. Ther. 2008, 119, 96-103.
58. Carr, A.; Frei, B. Does vitamin C act as a pro-oxidant under physiological conditions? Faseb. J. 1999, 13, 1007-1024.
59. Stocker, R.; Keaney, J.F., Jr. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 2005, 3, 1825-1834.
60. Tsukaguchi, H.; Tokui, T.; Mackenzie, B.; Berger, U.V.; Chen, X.Z.; Wang, Y.; Brubaker, R.F.; Hediger, M.A. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 1999, 399, 70-75.
61. Seno, T.; Inoue, N.; Matsui, K.; Ejiri, J.; Hirata, K.; Kawashima, S.; Yokoyama, M. Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J. Vasc. Res. 2004, 41, 345-351.
62. Sotiriou, S.; Gispert, S.; Cheng, J.; Wang, Y.; Chen, A.; Hoogstraten-Miller, S.; Miller, G.F.; Kwon, O.; Levine, M.; Guttentag, S.H.; Nussbaum, R.L. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 2002, 8, 514-517.
63. May, J.M.; Qu, Z.C. Transport and intracellular accumulation of vitamin C in endothelial cells: relevance to collagen synthesis. Arch. Biochem. Biophys. 2005, 434, 178-186.
64. Saeed, R.W.; Peng, T.; Metz, C.N. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells. Exp. Biol. Med. (Maywood) 2003, 228, 855-865.
65. Ulrich-Merzenich, G.; Metzner, C.; Schiermeyer, B.; Vetter, H. Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur. J. Nutr. 2002, 41, 27-34.
66. Rossig, L.; Hoffmann, J.; Hugel, B.; Mallat, Z.; Haase, A.; Freyssinet, J.M.; Tedgui, A.; Aicher, A.; Zeiher, A.M.; Dimmeler, S. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001, 104, 2182-2187.
67. Heller, R.; Unbehaun, A.; Schellenberg, B.; Mayer, B.; Werner-Felmayer, G.; Werner, E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 2001, 276, 40-47.
68. Ting, H.H.; Timimi, F.K.; Haley, E.A.; Roddy, M.A.; Ganz, P.; Creager, M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997, 95, 2617-2622.
69. Gokce, N.; Keaney, J.F., Jr.; Frei, B.; Holbrook, M.; Olesiak, M.; Zachariah, B.J.; Leeuwenburgh, C.; Heinecke, J.W.; Vita, J.A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99, 3234-3240.
70. Arakawa, E.; Hasegawa, K.; Irie, J.; Ide, S.; Ushiki, J.; Yamaguchi, K.; Oda, S.; Matsuda, Y. L-ascorbic acid stimulates expression of smooth muscle-specific markers in smooth muscle cells both in vitro and in vivo. J. Cardiovasc. Pharmacol. 2003, 42, 745-751.
71. Tomoda, H.; Yoshitake, M.; Morimoto, K.; Aoki, N. Possible prevention of postangioplasty restenosis by ascorbic acid. Am. J. Cardiol. 1996, 78, 1284-1286.
72. Azen, S.P.; Qian, D.; Mack, W.J.; Sevanian, A.; Selzer, R.H.; Liu, C.R.; Liu, C.H.; Hodis, H.N. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 1996, 94, 2369-2372.
73. Hodis, H.N.; Mack, W.J.; LaBree, L.; Cashin-Hemphill, L.; Sevanian, A.; Johnson, R.; Azen, S.P. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995, 273, 1849-1854.
74. Sesso, H.D.; Buring, J.E.; Christen, W.G.; Kurth, T.; Belanger, C.; MacFadyen, J.; Bubes, V.; Manson, J.E.; Glynn, R.J.; Gaziano, J.M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300, 2123-2133.